💊Press Announcements > FDA announces approval,

By FDA, Pharmaceutical

💊Press Announcements > FDA announces approval,

FDA announces approval, CMS proposes coverage of first breakthrough-designated test to detect extensive number of cancer biomarkers

FDA/CMS parallel review process makes test for efficient identification of multiple targeted therapy options available to health care professionals, patients and eligible Medicare beneficiaries‎ sooner.

The FDA granted approval for the F1CDx test to Foundation Medicine, Inc.

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm587273.htm

FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for opioid use disorder

FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for opioid use .disorder

The FDA granted the approval of Sublocade to Indivior Inc.

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm587312.htm

More from tokioX :

  1. 💊FDA takes action against 53 websites marketing unapproved opioids as part of a comprehensive effort to target illegal online sales
  2. 💊Otsuka’s JYNARQUE™ Approved by U.S. FDA as the First Treatment to Slow Kidney Function Decline in Adults at Risk of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease (ADPKD)
  3. 💊FDA PHARMA TODAY
  4. 💊FDA PHARMA TODAY
  5. 💊the latest FDA approval
  6. 💊FDA PHARMA today
  7. FDA approves gene therapy Luxturna for hereditary blindness